Association of therapeutic decision-making by clinical and breast cancer characteristics, CYP2D6 phenotype, previous knowledge of CYP2D6 testing, referral method, and interest in CYP2D6 testing. The gene discussed is CYP2D6; the disease is breast carcinoma.